18 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
environment, we feel that it is necessary and financially prudent to commence our Global Phase 3 program for CBP-201 in moderate-to-severe AD after we have
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
that it had determined, in light of the current macroeconomic climate and challenging funding environment, to commence its Global Phase 3 program
F-3/A
CNTB
Connect Biopharma Holdings Ltd
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
-based companies could adversely affect our business and results of operations. If the business environment in the PRC deteriorates from … business and results of operations. If the business environment in the PRC deteriorates from the perspective of domestic or international investment, the PRC
F-3/A
gcz 0jhmob
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
EX-1.2
cpopbo
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
d9q9mmw68
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
2qtkoro zms2
31 Mar 22
Annual report (foreign)
4:33pm
424B4
y0vi6zch3orgxp9g
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
51nenyur1k9
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
97mccac0
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
qqvrah ls
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
bvryyfxg
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.13
lgukae8
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
6xqiv ezk9d02rz
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
u1e bxhbhgd703
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
s933 vo92
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next